Cost-effectiveness analysis of adult pneumococcal conjugate vaccines for pneumococcal disease in Japan

Authors: Shigeki Nakamura, Masashi Mikami, Tomoyuki Hayamizu, Naohiro Yonemoto, Camille Moyon, Mark Gouldson, Catriona Crossan, Jeffrey Vietri, Kazumasa Kamei

Source: Expert Review of Vaccines, Vol 23, Iss 1, Pp 546-560 (2024)

Subject Terms: Cost-effectiveness, invasive pneumococcal disease, Japan, PCV20, pneumococcal disease, vaccination, Internal medicine, RC31-1245

File Description: electronic resource

Relation: https://doaj.org/toc/1476-0584; https://doaj.org/toc/1744-8395

Access URL: https://doaj.org/article/5239dd86e93040829e02bc8ac2bf6317

Cost-effectiveness analysis of 20-valent pneumococcal conjugate vaccine for routine pediatric vaccination programs in Japan

Authors: Masayoshi Shinjoh, Kanae Togo, Tomoyuki Hayamizu, Naohiro Yonemoto, Junko Morii, Johnna Perdrizet, Kazumasa Kamei

Source: Expert Review of Vaccines, Vol 23, Iss 1, Pp 485-497 (2024)

Subject Terms: Cost-effectiveness, Japan, PCV20, pneumococcal disease, vaccination, Internal medicine, RC31-1245

File Description: electronic resource

Relation: https://doaj.org/toc/1476-0584; https://doaj.org/toc/1744-8395

Access URL: https://doaj.org/article/71b05513c01b4d099126da3986cf1959

Cost-effectiveness analysis of 21-valent pneumococcal conjugated vaccine among adults in Canada

Authors: Ximenes, Raphael ^{a, ⁎}, Simmons, Alison E. ^{a, b}, Gebretekle, Gebremedhin B. ^a, Nam, Austin ^a, Wong, Eva ^a, Salvadori, Marina I. ^{a, c}, Golden, Alyssa R. ^d, Sander, Beate ^{e, f, g, h}, Hildebrand, Kyla J. ^{i, j}, Tunis, Matthew ^a, Tuite, Ashleigh R. ^{a, b}

Source: In Vaccine 30 April 2025 54

A phase 3 study of 20-valent pneumococcal conjugate vaccine in healthy toddlers previously vaccinated in infancy with 13-valent pneumococcal conjugate vaccine

Authors: Martinón-Torres, Federico ^a, Martinez, Silvina Natalini ^b, Kline, Mary J. ^{c, ⁎}, Drozd, Jelena ^c, Trammel, James ^c, Peng, Yahong ^c, Giardina, Peter C. ^d, Gruber, William C. ^{d, 1}, Watson, Wendy ^{c, 1}, Bickham, Kara ^{d, 1}, Tamimi, Noor ^c

Source: In Vaccine 19 April 2025 53

Serotype 15C Streptococcus pneumoniae resistant to classical complement deposition and agglutination by polyclonal rabbit anti-capsular 15B sera

Authors: Kochis, E.J. ^a, Shaik-Dasthagirisaheb, Y.B. ^b, Munarriz, N. ^a, Kretzmann, I. ^b, Nahm, M. ^c, Pelton, S.I. ^{b, d, ⁎, 1}, Lapidot, Rotem ^{b, d, e, f, 1}

Source: In Vaccine 2 December 2024 42(26)

The Health and Economic Effects of PCV15 and PCV20 During the First Year of Life in the US

Authors: Aleksandar Ilic, Maria J. Tort, Alejandro Cane, Raymond A. Farkouh, Mark H. Rozenbaum

Source: Vaccines, Vol 12, Iss 11, p 1279 (2024)

Subject Terms: pneumococcal conjugate vaccine (PCV), PCV20, PCV15, invasive pneumococcal disease (IPD), cost-effectiveness, vaccine effectiveness, Medicine

File Description: electronic resource

Relation: https://www.mdpi.com/2076-393X/12/11/1279; https://doaj.org/toc/2076-393X

Access URL: https://doaj.org/article/80a73adcd0ab4c55b00f1901c00ebb59

Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting

Authors: Mikkelsen Malene B, Husby Oyvind, Molden Tor, Mwaura David N, Olsen Jens, Kristensen Nanna V, Vietri Jeffrey

Source: Cost Effectiveness and Resource Allocation, Vol 21, Iss 1, Pp 1-15 (2023)

Subject Terms: Pneumococcal diseases, Pneumococcal infection, Vaccination, Cost-utility analysis, PCV20, 20-valent pneumococcal conjugate vaccine, Medicine (General), R5-920

File Description: electronic resource

Relation: https://doaj.org/toc/1478-7547

Access URL: https://doaj.org/article/3c350e411a46441d9fe8d353d49d3f86

Cost-Effectiveness Analysis of Routine Childhood Immunization with 20-Valent versus 15-Valent Pneumococcal Conjugate Vaccines in Germany

Authors: Min Huang, Jessica P. Weaver, Elamin Elbasha, Thomas Weiss, Natalie Banniettis, Kristen Feemster, Meghan White, Matthew S. Kelly

Source: Vaccines, Vol 12, Iss 9, p 1045 (2024)

Subject Terms: cost-effectiveness, PCV15, V114, PCV20, pneumococcal diseases, childhood immunization, Medicine

File Description: electronic resource

Relation: https://www.mdpi.com/2076-393X/12/9/1045; https://doaj.org/toc/2076-393X

Access URL: https://doaj.org/article/de7674a488e3451ebfcd4fe0e832ec3b

Assessing Public Health Impact of Four Pediatric Pneumococcal Conjugate Vaccination Strategies in the Netherlands

Authors: Michele Wilson, Cheryl McDade, Anna Trisia Beby-Heijtel, Angela Waterval-Overbeek, Vishalini Sundaram, Johnna Perdrizet

Source: Infectious Diseases and Therapy, Vol 12, Iss 7, Pp 1809-1821 (2023)

Subject Terms: Pneumococcal disease, Vaccine, PCV, PCV13, PCV20, Infectious and parasitic diseases, RC109-216

File Description: electronic resource

Relation: https://doaj.org/toc/2193-8229; https://doaj.org/toc/2193-6382

Access URL: https://doaj.org/article/e4f2250be4154cf89e7baf3d8ac9eb14

Historical Population-Level Impact of Infant 13-Valent Pneumococcal Conjugate Vaccine (PCV13) National Immunization Programs on Invasive Pneumococcal Disease in Australia, Canada, England and Wales, Israel, and the United States

Authors: Johnna Perdrizet, Emily K. Horn, Kyla Hayford, Lindsay Grant, Rachid Barry, Liping Huang, Cheryl McDade, Michele Wilson

Source: Infectious Diseases and Therapy, Vol 12, Iss 5, Pp 1351-1364 (2023)

Subject Terms: Pneumococcal disease, Indirect effects, Pneumococcal vaccination, Public health impact, PCV13, PCV20, Infectious and parasitic diseases, RC109-216

File Description: electronic resource

Relation: https://doaj.org/toc/2193-8229; https://doaj.org/toc/2193-6382

Access URL: https://doaj.org/article/a02a168a132041509e51588b17b29c26

Cost-Effectiveness Analysis of the South African Infant National Immunization Program for the Prevention of Pneumococcal Disease

Authors: Liping Huang, Cheryl L. McDade, Johnna E. Perdrizet, Michele R. Wilson, Sophie A. Warren, Susan Nzenze, Renilla Sewdas

Source: Infectious Diseases and Therapy, Vol 12, Iss 3, Pp 933-950 (2023)

Subject Terms: PCV, PCV13, PCV20, Pneumococcal disease, Vaccine, Infectious and parasitic diseases, RC109-216

File Description: electronic resource

Relation: https://doaj.org/toc/2193-8229; https://doaj.org/toc/2193-6382

Access URL: https://doaj.org/article/2621c9a97fcb4c118d30f699be4c6fda

Cost-utility of 20-valent pneumococcal conjugate vaccine compared to no vaccination and recommended alternative vaccines among Belgian adults

Authors: Sophie Marbaix, Annick Mignon, Audrey Taelman, Ahuva Averin, Mark Atwood, Jeffrey Vietri

Source: Expert Review of Vaccines, Vol 0, Iss 0 (2023)

Subject Terms: pneumococcal vaccination, pcv20, cost-effectiveness, cost-utility, adults, Internal medicine, RC31-1245

File Description: electronic resource

Relation: https://doaj.org/toc/1476-0584; https://doaj.org/toc/1744-8395

Access URL: https://doaj.org/article/da02285529f54d06838c55ed009d888a

Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece

Authors: George Gourzoulidis, Myrto Barmpouni, Vasiliki Kossyvaki, Jeffrey Vietri, Charalampos Tzanetakos

Source: Frontiers in Public Health, Vol 11 (2023)

Subject Terms: PCV20, PCV15, pneumococcal disease, Greece, pneumococcal conjugate vaccines, Public aspects of medicine, RA1-1270

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fpubh.2023.1229524/full; https://doaj.org/toc/2296-2565

Access URL: https://doaj.org/article/9eeacb46524d4f8dada9aed11373b463

Cost-effectiveness analysis of PCV20 to prevent pneumococcal disease in the Canadian pediatric population

Authors: Derek Lytle, Ana Gabriela Grajales Beltrán, Johnna Perdrizet, Nassim Ait Yahia, Alejandro Cane, Benjamin Yarnoff, Ruth Chapman

Source: Human Vaccines & Immunotherapeutics, Vol 19, Iss 2 (2023)

Subject Terms: pneumococcal disease, pcv20, cost-effectiveness analysis, Immunologic diseases. Allergy, RC581-607, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://doaj.org/toc/2164-5515; https://doaj.org/toc/2164-554X

Access URL: https://doaj.org/article/0feaf406272f41d088edaf6ce870bc53

Pneumococcal Serotypes Associated with Community-Acquired Pneumonia Hospitalizations in Adults in Spain, 2016–2020: The CAPA Study

Authors: Rosario Menéndez, Antoni Torres, Pedro Pablo España, Jose Alberto Fernández-Villar, José María Marimón, Raúl Méndez, Catia Cilloniz, Mikel Egurrola, Maribel Botana-Rial, María Ercibengoa, Cristina Méndez, Isabel Cifuentes, Bradford D. Gessner

Source: Microorganisms, Vol 11, Iss 11, p 2781 (2023)

Subject Terms: community-acquired pneumonia, pneumococcal conjugate vaccines, pneumococcal pneumonia, PCV20 serotypes, Biology (General), QH301-705.5

File Description: electronic resource

Relation: https://www.mdpi.com/2076-2607/11/11/2781; https://doaj.org/toc/2076-2607

Access URL: https://doaj.org/article/5d26f8790b414965b4e2062399a9d631

A randomized phase 1 study of the safety and immunogenicity of 2 novel pneumococcal conjugate vaccines in healthy Japanese adults in the United States

Authors: David Fitz-Patrick, Mariano Young Jr, Daniel A. Scott, Ingrid L. Scully, Gary Baugher, Yahong Peng, Kathrin U. Jansen, William Gruber, Wendy Watson

Source: Human Vaccines & Immunotherapeutics, Vol 17, Iss 7, Pp 2249-2256 (2021)

Subject Terms: streptococcus pneumoniae, clinical trial, pneumococcal conjugate vaccine, immunogenicity, safety, pcv20, cpcv7, Immunologic diseases. Allergy, RC581-607, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://doaj.org/toc/2164-5515; https://doaj.org/toc/2164-554X

Access URL: https://doaj.org/article/0b3347e2452941a9b4e2d5703b0f8e80

Pneumococcal Serotype Evolution and Burden in European Adults in the Last Decade: A Systematic Review

Authors: Rita Teixeira, Vasiliki Kossyvaki, Paulina Galvez, Cristina Méndez

Source: Microorganisms, Vol 11, Iss 6, p 1376 (2023)

Subject Terms: pneumococcal disease, PCV13, PCV15, PCV20, pneumococcal vaccination, public health, Biology (General), QH301-705.5

File Description: electronic resource

Relation: https://www.mdpi.com/2076-2607/11/6/1376; https://doaj.org/toc/2076-2607

Access URL: https://doaj.org/article/cf39a924c56d42abab282dc2a63c0d57

State Immunization Policies for Pharmacists Hinder US Vaccine Uptake

Authors: By:Brian Nowosielski

Source: Drug Topics (USA), March 11, 2025 News, 5pp